Analytical Data
-
基因名
E & M
- Application
-
别名
/
-
种属
Severe acute respiratory syndrome coronavirus 2
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0DTC4 & P0DTC5
-
表达区间
1-42aa
-
分子量
17.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of E & M recombinant proteins is rooted in the broader context of protein engineering and biotechnology, which aim to leverage the unique properties of proteins for various applications in medicine, industry, and research. E & M proteins, derived from specific genes or organisms, exhibit distinct functionalities that make them valuable for therapeutic and diagnostic purposes. The interest in these proteins has surged due to their potential in vaccine development, particularly in the context of infectious diseases and cancer, where they can trigger targeted immune responses. Furthermore, advancements in recombinant DNA technology have facilitated the production of these proteins in host systems such as bacteria, yeast, or mammalian cells, enhancing their yield and purity for experimental use. Researchers investigate the structural and functional characteristics of E & M proteins to understand their mechanisms of action and to optimize their applications. This research extends beyond basic science, contributing to the development of novel therapeutic strategies and biotechnological innovations. Overall, the exploration of E & M recombinant proteins represents a promising frontier in the intersection of immunology, molecular biology, and biotechnology, addressing critical challenges in health and disease management.
